David Johnson
Direttore/Membro del Consiglio presso CARIBOU BIOSCIENCES, INC.
Patrimonio netto: - $ in data 31/05/2024
Posizioni attive di David Johnson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 11/05/2022 | - |
| Independent Dir/Board Member | 11/05/2022 | - |
Storia della carriera di David Johnson
Precedenti posizioni note di David Johnson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Corporate Officer/Principal | 12/03/2018 | 01/12/2022 |
| GILEAD SCIENCES, INC. | Vendite & Marketing | 01/01/2003 | 01/01/2018 |
Formazione di David Johnson
| University of Puget Sound | Undergraduate Degree |
| Kenan-Flagler Business School | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
Posizioni
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| CARIBOU BIOSCIENCES, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- David Johnson
- Esperienza
